Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 2/20 | 0.56 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | ACE | P12821 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | DAO | P14920 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Stepronin SCHEMBL19339 | 1.00 | ELANE (0.56) | ELANETSHRKMT2AMEN1RAB9A | |
| Stepronin SCHEMBL1651441 | 0.87 | ELANE (0.54) | ELANETSHRKMT2AMEN1RAB9A | |
| Stepronin SCHEMBL6818585 | 0.83 | ELANE (0.48) | ELANETSHRKMT2AMEN1RAB9A | |
| SCHEMBL11176247 | 0.80 | ELANE (0.47) | ELANETSHRKMT2AMEN1ALDH1A1 | |
| SCHEMBL11189010 | 0.80 | ELANE (0.59) | ELANEKMT2AMEN1RAB9AALDH1A1 | |
| SCHEMBL11189007 | 0.80 | ELANE (0.59) | ELANEKMT2AMEN1RAB9AALDH1A1 | |
| SCHEMBL7314482 | 0.79 | ELANE (0.56) | ELANEKMT2AMEN1RAB9AALDH1A1 | |
| SCHEMBL10505335 | 0.79 | MME (0.48) | KMT2AMEN1ALDH1A1HPGDACE | |
| SCHEMBL11188353 | 0.78 | ELANE (0.55) | ELANEKMT2ARAB9AALDH1A1HPGD | |
| SCHEMBL11188356 | 0.78 | ELANE (0.55) | ELANEKMT2ARAB9AALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2249 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250255781-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-08-14 | — | — | US | claimed |
| WO-2025122957-A1 | PROTEASE ACTIVATABLE CYTOKINES AND METHODS FOR MAKING AND USING THE SAME | AMUNIX PHARMACEUTICALS, INC. (US) | 2025-06-12 | — | — | WO | claimed |
| US-12296043-B2 | Liquisoft capsules | PATHEON SOFTGELS INC. (US) | 2025-05-13 | — | — | US | claimed |
| EP-4510999-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | Bristol-Myers Squibb Company (US) | 2025-02-26 | — | — | EP | claimed |
| US-20240254098-A1 | THIOESTER PRODRUGS FOR THE TREATMENT OF RENAL ANOMALIES | ALTIBIO, INC. | 2024-08-01 | — | — | US | claimed |
| US-20240165020-A1 | LIQUISOFT CAPSULES | PATHEON SOFTGELS INC (US) | 2024-05-23 | — | — | US | claimed |
| EP-4360653-A2 | LIQUISOFT CAPSULES | Patheon Softgels Inc. (US) | 2024-05-01 | — | — | EP | claimed |
| US-11872307-B2 | Liquisoft capsules | PATHEON SOFTGELS INC. (US) | 2024-01-16 | — | — | US | claimed |
| EP-3682872-B1 | LIQUISOFT CAPSULES | PATHEON SOFTGELS INC (US) | 2024-01-03 | — | — | EP | claimed |
| WO-2023205619-A1 | PROCESSES FOR PREPARATION OF 3-D PRINTED PHARMACEUTICAL PRODUCTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2023-10-26 | — | — | WO | claimed |
| WO-2001012584-A2 | PHARMACEUTICAL COMPOUNDS | NICOX S.A. (FR) | 2001-02-22 | — | — | WO | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000061549-A2 | PHARMACEUTICAL COMPOUNDS | NICOX S.A. (FR) | 2000-10-19 | — | — | WO | claimed |
| WO-2000050050-A1 | MULTIPARTICULATE FORMULATION | ISIS PHARMACEUTICALS, INC. (US) | 2000-08-31 | — | — | WO | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| WO-1998022114-A1 | A METHOD FOR PROMOTING TISSUE REPAIR | DUMEX-ALPHARMA A/S (DK) | 1998-05-28 | — | — | WO | claimed |
| US-4845114-A | N-(trans-p-hydroxy-cyclohexyl)-(2-amino-3,5-dibromo)benzylamine salts possessing mucolytic activity | ERREGIERRE INDUSTRIA CHIMICA SPA (IT) | 1989-07-04 | — | — | US | claimed |
| EP-0274106-A2 | N-(trans-p-hydroxy-cyclohexyl)-(2-amino-3,5-dibromo)benzylamine salts possessing mucolytic activity | ERREGIERRE INDUSTRIA CHIMICA Spa (IT) | 1988-07-13 | — | — | EP | claimed |
| US-4405638-A | ANTITUSSIVE AGENTS; ANTIINFLAMMATORY AGENTS; RESPIRATORY SYSTEM DISORDERS | SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A (IT) | 1983-09-20 | — | — | US | claimed |
| US-4242354-A | LIVER DISEASES AND POISONING; MUCOLYTIC AND BRONCHIAL-SPASM RELIEVING | MEDIOLANUM FARMACEUTICI S.R.L. (IT) | 1980-12-30 | — | — | US | claimed |